Jupiter Neurosciences, Inc. Common Stock (JUNS) is a publicly traded Healthcare sector company. As of May 20, 2026, JUNS trades at $0.35 with a market cap of $12.06M and a P/E ratio of -1.38. JUNS moved +7.81% today. Year to date, JUNS is -68.32%; over the trailing twelve months it is -43.16%. Its 52-week range spans $0.31 to $19.51. Rallies surfaces JUNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for JUNS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.35 |
| Market Cap | $12.06M |
| P/E Ratio | -1.38 |
| EPS | $-0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.51 |
| 52-Week Low | $0.31 |
| Volume | 194.68M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.80K |
| Net Income | $-8.64M |
| Gross Margin | 0.00% |
JUNS analyst coverage data. Average price target: $0.00.